Jeff Slapp
@jeffslapp
Chief Technology Officer at SteelDome
ID: 1896903264
http://steeldome.com 23-09-2013 10:49:22
12,12K Tweet
350 Followers
83 Following
#COVID-19 vaccine co-development partner, Bharat Biotech shared 2nd interim results demonstrating 100% protection against severe disease (including hospitalization) and 78% primary efficacy in preventing #COVID-19. View today's release: bit.ly/3njh0lj
#BREAKING:World Health Organization (WHO) granted Emergency Use Listing approval to #COVID-19 vaccine COVAXIN™, developed by our partner Bharat Biotech. We are pleased this vaccine now has the potential to protect millions more people around the world from severe COVID-19 disease. ow.ly/GVq450GFcqB